Browsing by Author "Willem Venter"
Now showing 1 - 11 of 11
Results Per Page
Sort Options
Item Adherence resistance and viral suppression on dolutegravir in subSaharan Africa implications for the TLD eraSuzanne M McCluskey; Toby Pepperrell; Andrew Hill; Willem Venter; Ravindra K Gupta; M SiednerItem Cardiovascular toxicity of contemporary antiretroviral therapyAlinda Vos; Willem VenterItem Implications of weight gain with newer antiretrovirals 10year predictions of cardiovascular disease and diabeteskaitlyn McCann; Shahini Shah; Laura Hindley; Andrew Hill; A Et Al; Simiso Sokhela; Willem Venter; C SerenataItem Is there a role for doravirine in African HIV treatment programmes A large observational resistance study in South AfricaKim Steegen; Michelle Moorhouse; Annemarie Wensing; Willem Venter; Lucia HansItem Lowdose ritonavirboosted darunavir once daily versus ritonavirboosted lopinavir for participants with less than 50 HIV RNA copies per MlWRHI 052 a randomised openlabel phase 3 noninferiority trialWillem Venter; Michelle Moorhouse; Simiso Sokhela; Celicia Serenata; Godspower Akpomiemie; Ambar Qavi; Nonkululeko Mashabane; Natasha Arulappan; Joel Weibo Sim; et al et al; Tom Boyles; Sarah StaceyItem Performance assessment of four HIV selftest devices in South Africa A crosssectional studyMohammed Majam; Alex Fischer; Naleni Rhagnath; Vanessa Msolamba; Willem Venter; Laura Mazzola; Samanta Lalla-EdwardItem Retention in care and viral suppression after sameday ART initiation Oneyear outcomes of the SLATE I and II individually randomized clinical trials in South AfricaMhairi Maskew; Alana Brennan; Willem Venter; Matthew Fox; Lungisile Vezi; Sydney RosenItem Safety and efficacy of four drug regimens versus standardof care for the treatment of symptomatic outpatients with COVID19 A randomised openlabel multiarm phase 2 clinical trialNomathemba Chandiwana; C Kruger; H Johnstone; M Chughlay; C Ju; Yengiwe Dineka; E et al; Willem VenterItem Southern African HIV Clinicians Society genderaffirming healthcare guideline for South AfricaRutendo Bothma; Willem Venter; Anastacia Tomson; Chris/tine McLachlan; Camilla Wattrus; Kevin Adams; E et alItem The predicted risk of adverse pregnancy outcomes as a result of treatmentassociated obesity in a hypothetical population receiving tenofovir alafenamideemtricitabinedolutegravir tenofovir disoproxil fumarateemtricitabinedolutegravir or tenofovir disoSumbul Asif; Evangelia Baxevanidi; Andrew Hill; Willem Venter; Lee Fairlie; Masebole Masenya; Celicia Serenata; Simiso Sokhela; Nomathemba Chandiwana